NEO
Neogenomics Inc
Price:  
13.83 
USD
Volume:  
346,164.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NEO EV/EBITDA

-97.5%
Upside

As of 2024-05-30, the EV/EBITDA ratio of Neogenomics Inc (NEO) is 142.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NEO's latest enterprise value is 1,973.24 mil USD. NEO's TTM EBITDA according to its financial statements is 13.86 mil USD. Dividing these 2 quantities gives us the above NEO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 12.3x - 17.9x 14.8x
Forward P/E multiples 17.2x - 23.6x 21.5x
Fair Price (0.28) - 0.94 0.35
Upside -102.0% - -93.2% -97.5%
13.83 USD
Stock Price
0.35 USD
Fair Price

NEO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-30 144.33
2024-05-29 142.39
2024-05-28 145.15
2024-05-24 146.17
2024-05-23 142.94
2024-05-22 148.01
2024-05-21 151.14
2024-05-20 152.34
2024-05-17 151.33
2024-05-16 153.08
2024-05-15 154.37
2024-05-14 156.86
2024-05-13 158.98
2024-05-10 160.27
2024-05-09 157.78
2024-05-08 154.37
2024-05-07 158.43
2024-05-06 157.87
2024-05-03 155.94
2024-05-02 150.59
2024-05-01 143.59
2024-04-30 143.22
2024-04-29 155.20
2024-04-26 145.25
2024-04-25 142.57
2024-04-24 144.23
2024-04-23 145.43
2024-04-22 138.61
2024-04-19 139.63
2024-04-18 141.84
2024-04-17 141.01
2024-04-16 142.57
2024-04-15 141.65
2024-04-12 144.79
2024-04-11 148.75
2024-04-10 148.20
2024-04-09 155.20
2024-04-08 151.79
2024-04-05 152.43
2024-04-04 151.24
2024-04-03 151.97
2024-04-02 151.42
2024-04-01 156.77
2024-03-28 159.81
2024-03-27 155.02
2024-03-26 154.65
2024-03-25 150.96
2024-03-22 155.11
2024-03-21 157.23
2024-03-20 158.15